Bevacizumab added to the irinotecan and capecitabine combination for advanced colorectal cancer: a well-tolerated, active and convenient regimen.

Ardavanis, Alexandros; Kountourakis, Panteleimon; Mantzaris, Ioannis; Malliou, Savvoula; Doufexis, Dimitrios; Sykoutri, Despina; Fragos, Ioannis; Rigatos, Gerassimos

Ardavanis, Alexandros; Kountourakis, Panteleimon; Mantzaris, Ioannis; Malliou, Savvoula; Doufexis, Dimitrios; Sykoutri, Despina; Fragos, Ioannis; Rigatos, Gerassimos.

Affiliation

Ardavanis A; First Department of Medical Oncology, St. Savvas Anticancer Hospital, Athens, Greece. ardavanis@yahoo.com

Anticancer Res ; 28(5B): 3087-92, 2008.

Article in En | MEDLINE | ID: mdl-19031962

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Colorectal Neoplasms/drug therapy; Adult; Aged; Antibodies, Monoclonal/administration & dosage; Antibodies, Monoclonal/adverse effects; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Bevacizumab; Camptothecin/administration & dosage; Camptothecin/adverse effects; Camptothecin/analogs & derivatives; Capecitabine; Deoxycytidine/administration & dosage; Deoxycytidine/adverse effects; Deoxycytidine/analogs & derivatives; Disease-Free Survival; Female; Fluorouracil/administration & dosage; Fluorouracil/adverse effects; Fluorouracil/analogs & derivatives; Humans; Irinotecan; Male; Middle Aged; Retrospective Studies

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Anticancer Res Year: 2008 Document type: Article Affiliation country: Greece Country of publication: Greece

Search on Google

Add to My VHL

XML

PubMed Links